Home Minerva Biotechnologies Granted Worldwide License To iPS Technology
 

Keywords :   


Minerva Biotechnologies Granted Worldwide License To iPS Technology

2015-08-05 06:57:21| drugdiscoveryonline Home Page

Minerva Biotechnologies and iPS Academia Japan, Inc. announced recently that they have signed an agreement granting Minerva worldwide rights to use and commercialize the induced Pluripotent Stem (iPS) cells patent portfolio arising from the work of Professor Shinya Yamanaka, MD, Ph.D., who won the Nobel Prize for Medicine in 2012 for his discovery of four genes that can reprogram an adult’s cell to go back in time to become that person’s own stem cell

Tags: technology license worldwide granted

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.11Eastern North Pacific Tropical Weather Outlook
24.11Atlantic Tropical Weather Outlook
24.11
24.11sobbat DB4R
24.11RC10
24.11 Knicks
24.11 W6S-JP001
24.11SALOMON XLT 150
More »